These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26060477)

  • 1. In vitro evidence for endocrine-disrupting chemical (EDC)'s inhibition of drug metabolism.
    Li WP; Wang YF; Gao J; Yu ML; Yu YY; Yao YQ
    Afr Health Sci; 2014 Mar; 14(1):185-8. PubMed ID: 26060477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evidence of baicalein's inhibition of the metabolism of zidovudine (AZT).
    Wang YC; Yang HY; Kong LT; Yu FX
    Afr Health Sci; 2014 Mar; 14(1):173-7. PubMed ID: 26060475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered AZT (3'-azido-3'-deoxythymidine) glucuronidation kinetics in liver microsomes as an explanation for underprediction of in vivo clearance: comparison to hepatocytes and effect of incubation environment.
    Engtrakul JJ; Foti RS; Strelevitz TJ; Fisher MB
    Drug Metab Dispos; 2005 Nov; 33(11):1621-7. PubMed ID: 16049128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.
    Hanioka N; Naito T; Narimatsu S
    Chemosphere; 2008 Dec; 74(1):33-6. PubMed ID: 18990428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine.
    Sun H; Zhang T; Wu Z; Wu B
    J Pharm Sci; 2015 Jan; 104(1):244-56. PubMed ID: 25393417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.
    Court MH; Krishnaswamy S; Hao Q; Duan SX; Patten CJ; Von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 2003 Sep; 31(9):1125-33. PubMed ID: 12920168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional UDP-glucuronyltransferase 2B15 polymorphism and bisphenol A concentrations in blood: results from physiologically based kinetic modelling.
    Partosch F; Mielke H; Gundert-Remy U
    Arch Toxicol; 2013 Jul; 87(7):1257-64. PubMed ID: 23404680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights for the risk of bisphenol A: inhibition of UDP-glucuronosyltransferases (UGTs).
    Jiang HM; Fang ZZ; Cao YF; Hu CM; Sun XY; Hong M; Yang L; Ge GB; Liu Y; Zhang YY; Dong Q; Liu RJ
    Chemosphere; 2013 Oct; 93(6):1189-93. PubMed ID: 23948605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjugation and deconjugation reactions within the fetoplacental compartment in a sheep model: a key factor determining bisphenol A fetal exposure.
    Corbel T; Perdu E; Gayrard V; Puel S; Lacroix MZ; Viguié C; Toutain PL; Zalko D; Picard-Hagen N
    Drug Metab Dispos; 2015 Apr; 43(4):467-76. PubMed ID: 25576162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of genistein glucuronidation by bisphenol A in human and rat liver microsomes.
    Coughlin JL; Thomas PE; Buckley B
    Drug Metab Dispos; 2012 Mar; 40(3):481-5. PubMed ID: 22146138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of various drugs on the glucuronidation of zidovudine (azidothymidine; AZT) by human liver microsomes.
    Sim SM; Back DJ; Breckenridge AM
    Br J Clin Pharmacol; 1991 Jul; 32(1):17-21. PubMed ID: 1909542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes.
    Mano Y; Usui T; Kamimura H
    Drug Metab Dispos; 2007 Apr; 35(4):602-6. PubMed ID: 17267620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation.
    Uchaipichat V; Winner LK; Mackenzie PI; Elliot DJ; Williams JA; Miners JO
    Br J Clin Pharmacol; 2006 Apr; 61(4):427-39. PubMed ID: 16542204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically Based Pharmacokinetic (PBPK) Modeling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes.
    Karrer C; Roiss T; von Goetz N; Gramec Skledar D; Peterlin Mašič L; Hungerbühler K
    Environ Health Perspect; 2018 Jul; 126(7):077002. PubMed ID: 29995627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucuronidation of 3'-azido-3'-deoxythymidine catalyzed by human liver UDP-glucuronosyltransferase. Significance of nucleoside hydrophobicity and inhibition by xenobiotics.
    Resetar A; Minick D; Spector T
    Biochem Pharmacol; 1991 Jul; 42(3):559-68. PubMed ID: 1907149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of bisphenol A glucuronidation according to UGT1A1*28 polymorphism by a new LC-MS/MS assay.
    Trdan Lušin T; Roškar R; Mrhar A
    Toxicology; 2012 Feb; 292(1):33-41. PubMed ID: 22154984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine.
    Boase S; Miners JO
    Br J Clin Pharmacol; 2002 Nov; 54(5):493-503. PubMed ID: 12445028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphenol A (BPA) may be released in the oral cavity after sealant placement.
    Kanuga S
    J Am Dent Assoc; 2014 Dec; 145(12):1272-3. PubMed ID: 25429042
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of bisphenol A with human UDP-glucuronosyltransferase 1A6 enzyme.
    Hanioka N; Takeda Y; Tanaka-Kagawa T; Hayashi K; Jinno H; Narimatsu S
    Environ Toxicol; 2008 Jun; 23(3):407-12. PubMed ID: 18214896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro glucuronidation of 3'-azido-3'-deoxythymidine by human liver. Role of UDP-glucuronosyltransferase 2 form.
    Rajaonarison JF; Lacarelle B; De Sousa G; Catalin J; Rahmani R
    Drug Metab Dispos; 1991; 19(4):809-15. PubMed ID: 1680659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.